Detecting Cannabinoids: From GC-MS to Biosensors

Cannabinoids like THC and CBD are increasingly being studied as options for managing chronic and nerve-related pain. Using them in clinical settings is tricky, however, since products vary widely, doctors aren't sure what the right dose range should be, and there isn't enough solid evidence linking specific amounts in the body to specific effects. Plenty of tools have been developed to detect cannabinoids, but few studies have connected how well these tools perform with what's really needed for monitoring pain treatment and drug levels in patients. A recent review article in the Journal of Pharmaceutical and Biomedical Analysis¹ rounds up the current landscape of cannabinoid detection tools. This includes both traditional lab techniques (like chromatography, mass spectrometry, and spectroscopy) and newer sensor-based technologies (like electronic sensors, color-changing tests, light-based and fluorescent detectors, antibody-based tests, sensors made from novel materials, and tools based on biological receptors or cells). The authors compare these different approaches based on what they can detect, what body fluids or samples they work with, how accurate and reliable they are, how well they've been tested, and how realistic it is that they could be used in clinical practice.

What Are Cannabinoids?

Cannabinoids are a broad group of active compounds that work by interacting with the body's endocannabinoid system, latching onto two main types of receptors known as CB1 and CB2.² These compounds come from three main sources: plants (called phytocannabinoids), the body's own natural production (called endocannabinoids), and laboratory-made synthetic versions.³ Plant-based cannabinoids mostly come from the cannabis plant, which contains over 125 different cannabinoids among more than 500 total compounds found in it.⁴ Of these, -tetrahydrocannabinol(THC), cannabidiol (CBD), and cannabinol (CBN) are the most well-studied.^5,6 THC is the cannabinoid responsible for cannabis's psychoactive effects (the "high" people associate with it)⁷ while CBD, CBN, and several other lesser-known cannabinoids do not produce that effect.^8,9 Instead, they are linked to benefits like reducing inflammation, protecting nerve cells, and relieving pain.^10-12

What Methods Exist for Measuring Cannabinoids in the Body, and What is Needed Before Newer Sensing Technologies Can Be Used in Real Clinical Care?

This review looks at both the older, established lab methods and newer, cutting-edge tools for measuring cannabinoids (like THC and CBD) in the body. While the traditional methods such as chromatography, mass spectrometry, and spectroscopyare the gold standard that everything else gets measured against, newer technologies have emerged, including electronic sensors, color-changing tests, light-based detectors, antibody-based tests, specially designed plastic sensors, paper strips, tiny lab-on-a-chip devices, and even sensors built from biological materials or cells. These newer tools tend to be more portable, cheaper, and better suited for quick testing right at the point of care, rather than requiring a full laboratory.¹

Of all these newer options, small electronic sensors and compact light-based or antibody tests seem closest to being usable in clinics soon, due to their being fast, need only a tiny sample, relatively easy to use, and work well for quick, on-the-spot testing. Other approaches, like color-changing tests, sensors made from experimental materials, breath-based tests, and advanced biological sensors, are still useful for early-stage screening or research purposes, but they need more testing before doctors could rely on them.¹

Even though there's been a lot of progress, most of these cannabinoid-sensing tools are still in the early stages of development. Some major issues remain, however: they have not been tested enough on real patient samples, they haven't been compared enough against the gold-standard lab methods, and there hasn't been enough investigation into whether other similar substances in the body could throw off the results. There is also not enough information yet on how consistent and reliable these devices are over time, or how well they're calibrated and quality checked. On top of that, scientists still do not fully understand how specific cannabinoid levels relate to pain relief or potential harm, so for now, these measurements should be treated as helpful extra information rather than the sole basis for making treatment decisions.¹

For these tools to actually make it into everyday clinical use, future devices will need to meet certain performance standards — tested properly in real human samples, shown to match up well with trusted laboratory methods, and clearly linked to things like dosage, how the drug was taken, timing, and whether it's working or causing side effects. Meeting these standards will be key to turning these promising sensors into dependable tools doctors can use to monitor cannabinoid therapy and support better, evidence-based pain management.¹

Read More on Similar Topics

The LCGC Blog: Avenues of Circumvention and Issues with Cannabis Products: Δ8-THC, THCA Flower, and Forensics Analysis

References

1. Banik, S.; Fales, J.; Kim, J. H. Biosensing Technologies for Cannabinoid Monitoring in Pain Management: Current Methods, Clinical Needs, and Translational Challenges. J Pharm Biomed Anal. 2026, 281, 117673. DOI: 10.1016/j.jpba.2026.117673
2. Arvind Kulkarni, V.; Pramod Nimje, H.; Purushottam Varhade, P. et al. Cannabinoid Pharmacology: Research on Medicinal Cannabins and its Therapeutic Application. J. Pharm. Biol. Sci2025, 12 (2), 135-143. DOI: 10.18231/j.jpbs.2024.020
3. Voicu, V.; Brehar, F.-M.; Toader, C. et al.Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy. Biomolecules 2023, 13 (9), 1388. DOI: 10.3390/biom13091388
4. Radwan, M. M.; Chandra, S.; Gul, S. et al. Cannabinoids, Phenolics, Terpenes and Alkaloids of Cannabis. Molecules 2021, 26 (9), 2774. DOI: 10.3390/molecules26092774
5. Blebea, N. M.; Pricopie, A. I.; Vlad, R.-A. et al. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use. Int. J. Mol. Sci. 2024, 25 (8), 4204. DOI: 10.3390/ijms25084204
6. Khouchlaa, A.; S. Khouri, S.; A. Hajib, A. et al. Health Benefits, Pharmacological Properties, and Metabolism of Cannabinol: A Comprehensive Review. Ind. Crop. Prod. 2024, 213, 118359. DOI: 10.1016/j.indcrop.2024.118359
7. Messina, G.; Rovelli, F.; Lissoni, P. A Review of On the Psychobiological Differences among Tetrahydrocannabinol, Cannabinol, Cannabidiol and Cannabigerol. Clin. Rev. Cases2022, 4 (3). DOI: 10.33425/2689-1069.1040
8. Martínez, V.; Iriondo De-Hond, A.; Borrelli, F. et al. Cannabidiol and Other Non-Psychoactive Cannabinoids for Prevention and Treatment of Gastrointestinal Disorders: Useful Nutraceuticals? Int. J. Mol. Sci.2020, 21 (9), 3067. DOI: 10.3390/ijms21093067
9. Maioli, C.; Mattoteia, D.; Amin, H. I. M. et al. Cannabinol: History, Syntheses, and Biological Profile of the Greatest “Minor” Cannabinoid. Plants2022, 11 (21), 2896. DOI: 10.3390/plants11212896
10. Wang, Y.; Wang, X.; Yang, Y. et al. Comparison of the in vitro Anti-Inflammatory Effect of Cannabidiol to Dexamethasone. Clin. Cosmet. Investig. Dermatol.2022, 15, 1959-1967, 10.2147/CCID.S378798
11. Kim, J.; Choi, J. Y.; Seo, J. et al. Neuroprotective Effect of Cannabidiol Against Hydrogen Peroxide in Hippocampal Neuron Culture. Cannabis Cannabinoid Res. 2021, 6 (1), 40-47. DOI: 10.1089/can.2019.0102
12. Miost, J.; M. Bryk, M.; K. Starowicz, K. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action. Int. J. Mol. Sci.2020, 21 (22), 8870. DOI: 10.3390/ijms21228870